Document Detail

Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study.
MedLine Citation:
PMID:  8353275     Owner:  NLM     Status:  MEDLINE    
The t(1;19)(q23;p13) translocation occurs in approximately 5% of B-precursor acute lymphoblastic leukemias (ALLs) occurring in children. Its presence has been associated with a poor prognosis, which may be overcome with more intensive therapy. Although leukemic cells from cases of t(1;19)-ALL frequently express cytoplasmic mu heavy chains, their complete antigenic profile remains undefined. Among 697 consecutive cases of B-precursor ALL with complete phenotypic studies using a panel of monoclonal antibodies, 22 cases were found to carry the t(1;19). Twenty of 22 cases had an identical, complex phenotype characterized by homogeneous expression of CD19, CD10, and CD9; complete absence of CD34; and at least partial absence of CD20. Overall, this phenotype was seen in only 8.0% (56 of 697) of childhood B-precursor ALL. One of the two remaining t(1;19)-carrying cases conformed to this phenotype, but was lacking data for CD9. The other case differed by virtue of expression of CD34 and was also hyperdiploid with 55 chromosomes. Molecular studies showed E2A-PBX1 abnormalities in all examined cases (12 of 12) with the t(1;19), including the case lacking CD9 data. In contrast, no E2A-PBX1 abnormalities were detected in the sole t(1;19)-ALL with CD34 expression. Seventeen cases with the characteristic phenotype and uninformative cytogenetics were also molecularly analyzed and 5 of 17 (including 4 of 8 with unsatisfactory cytogenetics and 1 of 9 with a normal karyotype) contained E2A gene rearrangements and E2A-PBX1 fusion mRNAs. Our results show that all cases of t(1;19)-ALL with concomitant E2A-PBX1 fusion invariably express a characteristic but uncommon profile of surface antigens. These observations suggest that selective molecular analysis of a small subset of patients (those with uninformative cytogenetics and the characteristic phenotype) can identify a significant number of additional cases of ALL with E2A-PBX1 fusion that might benefit from more intensive therapy.
M J Borowitz; S P Hunger; A J Carroll; J J Shuster; D J Pullen; C P Steuber; M L Cleary
Related Documents :
17506065 - Benzene-induced acute myeloid leukemia: a clinician's perspective.
6774565 - Analysis of 75 cases of acute myeloid leukaemia classified according to the fab classif...
6581855 - Relapse of acute myelogenous leukemia presenting as acute otitis externa. a case report.
21552445 - Esophageal small cell carcinoma with synchronous renal cell carcinoma: a case report wi...
9923525 - Three cases of tuberculosis after heart transplantation in spain.
21838085 - Ischemic onycholysis of the hands.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Blood     Volume:  82     ISSN:  0006-4971     ISO Abbreviation:  Blood     Publication Date:  1993 Aug 
Date Detail:
Created Date:  1993-09-17     Completed Date:  1993-09-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1086-91     Citation Subset:  AIM; IM    
Duke University Medical Center, Durham, NC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, CD / analysis*
Chromosomes, Human, Pair 1*
Chromosomes, Human, Pair 19*
Gene Rearrangement
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*,  immunology
Translocation, Genetic*
Grant Support
1F32 CA 09184-01/CA/NCI NIH HHS; CA 429971/CA/NCI NIH HHS
Reg. No./Substance:
0/Antigens, CD

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The chromosome 4q21 gene (AF-4/FEL) is widely expressed in normal tissues and shows breakpoint diver...
Next Document:  Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosi...